Search research articles
Contact Us
Filters
Showing results (81-90 of 179) with videos related to
Page
of 18
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 25, 2022
Outcomes in Patients with Poor-Risk Cytogenetics with or without TP53 Mutations Treated with Venetoclax and Azacitidine
Daniel A Pollyea, Keith W Pratz, Andrew H Wei, et al.
Molecular Cancer Therapeutics
|
March 18, 2004
TNP-470 promotes initial vascular sprouting in xenograft tumors
Jianzhong Huang, Jason S Frischer, Tamara New, et al.
Blood Advances
|
December 21, 2021
Atezolizumab alone or in combination did not demonstrate a favorable risk-benefit profile in myelodysplastic syndrome
Aaron T Gerds, Bart L Scott, Peter Greenberg, et al.
Blood
|
November 1, 2024
Refined ELN 2024 risk stratification improves survival prognostication following venetoclax-based therapy in AML
Curtis A Lachowiez, Vishvaas I Ravikumar, Jad Othman, et al.
Blood
|
September 15, 2021
The STAT3-MYC axis promotes survival of leukemia stem cells by regulating SLC1A5 and oxidative phosphorylation
Maria L Amaya, Anagha Inguva, Shanshan Pei, et al.
Haematologica
|
June 19, 2025
The STAT3-VDAC1 axis modulates mitochondrial function and plays a critical role in the survival of acute myeloid leukemia cells
Kellen B Gil, Jamie Borg, Rosana Moreira Pereira, et al.
Journal of Leukocyte Biology
|
November 6, 2020
MDS-associated SF3B1 mutations enhance proinflammatory gene expression in patient blast cells
Daniel A Pollyea, Hyun Min Kim, Brett M Stevens, et al.
Blood
|
August 26, 2025
Plasma lipid levels predict chemotherapy response and survival in acute myeloid leukemia
Cristiana O'Brien, Nirvana Nursimulu, Anit Tyagi, et al.
Leukemia & Lymphoma
|
September 22, 2015
Clonality of neutrophilia associated with plasma cell neoplasms: report of a SETBP1 mutation and analysis of a single institution series
Brett Stevens, Julia Maxson, Jeffrey Tyner, et al.
Haematologica
|
December 18, 2023
Multi-gene measurable residual disease assessed by digital polymerase chain reaction has clinical and biological utility in acute myeloid leukemia patients receiving venetoclax/azacitidine
Amanda C Winters, Mohd Minhajuddin, Brett M Stevens, et al.
Page
of 18
Search research articles
Search
Showing results (81-90 of 179) with videos related to
Sort By:
Page
of 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 25, 2022
Outcomes in Patients with Poor-Risk Cytogenetics with or without TP53 Mutations Treated with Venetoclax and Azacitidine
Daniel A Pollyea, Keith W Pratz, Andrew H Wei, et al.
Molecular Cancer Therapeutics
|
March 18, 2004
TNP-470 promotes initial vascular sprouting in xenograft tumors
Jianzhong Huang, Jason S Frischer, Tamara New, et al.
Blood Advances
|
December 21, 2021
Atezolizumab alone or in combination did not demonstrate a favorable risk-benefit profile in myelodysplastic syndrome
Aaron T Gerds, Bart L Scott, Peter Greenberg, et al.
Blood
|
November 1, 2024
Refined ELN 2024 risk stratification improves survival prognostication following venetoclax-based therapy in AML
Curtis A Lachowiez, Vishvaas I Ravikumar, Jad Othman, et al.
Blood
|
September 15, 2021
The STAT3-MYC axis promotes survival of leukemia stem cells by regulating SLC1A5 and oxidative phosphorylation
Maria L Amaya, Anagha Inguva, Shanshan Pei, et al.
Haematologica
|
June 19, 2025
The STAT3-VDAC1 axis modulates mitochondrial function and plays a critical role in the survival of acute myeloid leukemia cells
Kellen B Gil, Jamie Borg, Rosana Moreira Pereira, et al.
Journal of Leukocyte Biology
|
November 6, 2020
MDS-associated SF3B1 mutations enhance proinflammatory gene expression in patient blast cells
Daniel A Pollyea, Hyun Min Kim, Brett M Stevens, et al.
Blood
|
August 26, 2025
Plasma lipid levels predict chemotherapy response and survival in acute myeloid leukemia
Cristiana O'Brien, Nirvana Nursimulu, Anit Tyagi, et al.
Leukemia & Lymphoma
|
September 22, 2015
Clonality of neutrophilia associated with plasma cell neoplasms: report of a SETBP1 mutation and analysis of a single institution series
Brett Stevens, Julia Maxson, Jeffrey Tyner, et al.
Haematologica
|
December 18, 2023
Multi-gene measurable residual disease assessed by digital polymerase chain reaction has clinical and biological utility in acute myeloid leukemia patients receiving venetoclax/azacitidine
Amanda C Winters, Mohd Minhajuddin, Brett M Stevens, et al.
Page
of 18